Original Source(s)
IBC Oxford 2025 Programme
January 23, 2026
Related Content
ACP Suggests First-Line Obesity Drugs
Semaglutide and tirzepatide had the greatest net benefit among evaluated treatments, the committee concluded.
June 16, 2026
-
5 min
Sleep Study Cutoffs May Guide Discharge
Preoperative sleep study values may distinguish lower-risk children within a population for whom overnight admission is currently routine.
June 5, 2026
-
6 min